Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomasSusan Dababou, Fabio Barra, Massimo Piergiuseppe Franchi et al.|Expert Opinion on Investigational Drugs|2021Cited by 62
Risk-Reducing Salpingo-Oophorectomy (RRSO) Combined with Simultaneous Mastectomy in Women with BRCA 1–2 Mutation Carriers: The Surgical Technique, the Feasibility and Patients’ Satisfaction of Multiple SurgeriesCarlo Saccardi, Roberto Tozzi, Silvia Michieletto et al.|Journal of Clinical Medicine|2022Cited by 10
743 Feasibility and the efficacy of RRSO combined with simultaneous mastectomy and breast reconstruction in BRCA 1–2 patientsGiulio Bonaldo, Carlo Saccardi, Marco Noventa et al.|International Journal of Gynecological Cancer|2021Cited by 0